At the core of these transformations are novel production processes that allow a far greater degree of manufacturing automation than has been possible with conventional production systems. Their rollout has enabled higher quality and consistency of production while improving production yield and reducing manufacturing cycle time. In addition, these investments have further reduced the environmental impact of production activities, benefiting local environments and allowing for reductions in environmental taxes.
5N Plus is the world's largest producer of bismuth-based Active Pharmaceutical Ingredients (API) used in the treatment of conditions ranging from gastro-intestinal complications to mastitis and bacteria–related conditions. The Company's facility in Lubeck,
Paul Tancell, Executive Vice President for Eco-Friendly Materials at 5N Plus, commented: "We are delighted with the improvements enabled by the recent package of investments. The new processes constitute fundamental changes to the production environments in our principal manufacturing sites. Furthermore, the investment program has enhanced the competitiveness of our global operations and positioned our businesses for future growth and profitability."
Mr. Tancell added: "We will continue to harness all opportunities afforded by process and production technologies that enable reductions in operating costs and improvements to the environment and communities in which we are present."
About 5N Plus Inc.
5N Plus is a leading global producer of engineered materials and specialty chemicals with integrated recycling and refining assets to manage the sustainability of its business model. The Company is headquartered in
Forward-Looking Statements and Disclaimer
Certain statements in this press release may be forward-looking within the meaning of applicable securities laws. Forward-looking information and statements are based on the best estimates available to the Company at the time and involve known and unknown risks, uncertainties or other factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. A description of the risks affecting the Company's business and activities appears under the heading "Risk and Uncertainties" of the 5N Plus' 2019 MD&A dated
The Company is not aware of any significant changes to its risk factors previously disclosed, however since
Forward-looking statements can generally be identified by the use of terms such as "may", "should", "would", "believe", "expect", the negative of these terms, variations of them or any similar terms. No assurance can be given that any events anticipated by the forward-looking information in this press release will transpire or occur, or if any of them do so, what benefits that 5N Plus will derive therefrom. In particular, no assurance can be given as to the future financial performance of 5N Plus. The forward-looking information contained in this press release is made as of the date hereof and the Company has no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws. The reader is warned against placing undue reliance on these forward-looking statements.
SOURCE
© Canada Newswire, source